A 10-year analysis of patients with type 2 diabetes treated with pioglitazone (Actos) found no statistically significant increased risk of bladder cancer, either with any exposure or for long duration of use.
No Cancer Link to Actos Long Term in TII Patients
Posted in Drugs Medical Research